Effect of PTEN/P13K Mutations on Gene Expression Profiling of Lung Cancer Cells

YAN Qun,ZOU Ming-xiang,LIU Wen-en,MA Jian

DOI: https://doi.org/10.3781/j.issn.1000-7431.2012.06.005

2012-01-01

Tumor

Abstract:Objective: To investigate the effect of PTEN (phosphatase and tensin homolog deleted on chromosome ten)/ PI3K (phosphoinositide 3-kinase) mutation on gene expression profiling of lung cancer cell lines. Methods: PTEN protein expression levels were analyzed by Western blotting, and the PTEN gene mutation was confirmed by sequencing in 19 NSCLC (non-small cell lung cancer) cell lines. The effect of PTEN gene mutation on the downstream AKT and mTOR pathways was also examined by Western blotting. GSEA (Gene set enrichment analysis) was employed to investigate the difference of gene expression profiling induced by PTEN/PI3K mutation in 19 NSCLC cell lines. Results: In this study, 19 NSCLC cell lines had been screened, and 5 cell lines had no PTEN protein expression and harbored PTEN mutation. Other 2 cell lines had PIK3CA mutation, which was found by database retrieval. The mutation of PTEN gene had a significant impact on the continuous activation of its downstream molecules AKT and mTOR pathways. GSEA was used to compare the gene expression profiling characters between the CON (without PTEN or PIK3CA mutation) and the MUT (with PTEN or PIK3CA mutation) groups of NSCLC cell lines. It was surprising that the most enriched gene set affected by PTEN/PI3K dysfunction was the mitochondrial-metabolism gene set. Conclusion: Mutation of PTEN/PI3K may affect its downstream molecules AKT and mTOR pathways as well as the lung cancer cells’ gene expression profiling, especially for the mitochondrial-metabolism gene set. This finding implies the importance of mitochondrial-metabolism regulation in lung cancer development. DOI:10.3781/j.issn.1000-7431.2012.06.005